In order to increase manufacturing capacity and to
supply materials smoother, we are planning to invest 14.5 billion won which is
19.14% of the capital in building a new manufacturing plant.
By applying the manufacturing process of the pharmaceutical
companies, we plan to build an optimal hygienic environment and a tour line
that shows the chain of manufacturing process to minimize
the number of defective
products and to secure production transparency and accessibility.
We will do our best to manufacture trustworthy
products with absolute hygiene management and smooth manufacturing at our new
plant. Thank you.